MedPath

Dexamethasone Sodium Phosphate

Dexamethasone Sodium Phosphate Ophthalmic Solution USP, 0.1% Dexamethasone Phosphate Equivalent(Sterile)

Approved
Approval ID

0de5bcce-0cc2-4b49-bd0d-714f1c7ec3bf

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 4, 2010

Manufacturers
FDA

Butler Animal Health Supply

DUNS: 017880659

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone Sodium Phosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code11695-1411
Application NumberANDA040069
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone Sodium Phosphate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateAugust 30, 2010
FDA Product Classification

INGREDIENTS (11)

CREATININEInactive
Code: AYI8EX34EU
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PHENETHYL ALCOHOLInactive
Code: ML9LGA7468
Classification: IACT
DEXAMETHASONE SODIUM PHOSPHATEActive
Quantity: 1 mg in 1 mL
Code: AI9376Y64P
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM BISULFITEInactive
Code: TZX5469Z6I
Classification: IACT
SODIUM BORATEInactive
Code: 91MBZ8H3QO
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone Sodium Phosphate - FDA Drug Approval Details